Correction: Generation and Characterization of New Entrance Antiretroviral Drug 2-Indolinone: Results of a Classical R & D Study

Ramesh Paranjape and Rahul Hajare
Additional contact information
Ramesh Paranjape: National AIDS Research Institute, India
Rahul Hajare: Indian Council of Medical Research, Vinayaka Mission University, India

Organic & Medicinal Chemistry International Journal, 2018, vol. 6, issue 2, 46-49

Abstract: HIV has true evolutionary history of a homologous of sequences. It has mutations do not have appreciated. It has some other property and impact on the fitness of the HIV carrier indicates how these analyses can be useful in the drug discovery process. HIV has same organ under every variety of form and function. It has variety of forms this definition still holds secrete even today. HIV has been come homologous proteins can differ in their specificities, specific activities, level of expression or some other basic property. However homologous will have some residual similarity in their form and function. HIV from all of its hiding places within the body has difficult. The approach can be used in bioinformatics innovation in practices, including complex binding energy estimation in novel HIV-1 inhibitors. Here we showed how a space filling model-based approach used infection HIV-1 inhibitors and role of target compound located insight into the host cell machinery. Process technology by parallel synthesizer major has used for the purposes of synthesized 2- Indolinones potential derivatives. In vitro anti-HIV-1 activity of new entrance compound 8-methoxy-5-(morpholin-4-ylmethyl)-4,4a,5,9b-tetrahydro-1H-pyrazino[2,3-b]indole-2,3 dicarbonitrile (1b) and studies have suggested that above has a novel reservoir has very low cytotoxicity(CC50>1mM) and it has been displays 15.5μg/ml to cell lines, TZM-bl. Also it displayed potent anti-HIV-1 activity and found 3.96μg/ml against laboratory adapted strains UG070, 7th PID.

Keywords: juniper publishers:Medicinal Chemistry; Biochemistry Journal; Pharmacology Journal; biochemical pharmacology; molecular pharmacology; biochemistry; open access journals; peer reviewed journals; Open Access; Journal of Molecular Biochemistry; International Research Journal of Pure and Applied Chemistry; World Journal of Biological Chemistry; Biochemistry and Analytical Biochemistry; Biochemistry & Physiology: Open Access; Molecular Biology International; Plant Biochemistry & Physiology; International Journal of Molecular Sciences; Journal of Clinical and Medical Genomics; Environmental Analytical Chemistry; Medicinal Chemistry; Juniper publishers reivews (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/omcij/pdf/OMCIJ.MS.ID.555685.pdf (application/pdf)
https://juniperpublishers.com/omcij/OMCIJ.MS.ID.555685.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jomcij:v:6:y:2018:i:2:p:46-49

DOI: 10.19080/OMCIJ.2018.06.555685

Access Statistics for this article

Organic & Medicinal Chemistry International Journal is currently edited by Sophia Mathis

More articles in Organic & Medicinal Chemistry International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().